Monkeypox is a viral disease that occurs in humans and some animals. It is caused by the monkeypox virus, which belongs to the same family of viruses as smallpox. Monkeypox most commonly spreads through direct contact with infected animals or humans. Initial symptoms include fever, headache, muscle aches, and swollen lymph nodes. Within a few days, a rash develops on the face and spreads to other parts of the body. While monkeypox is generally mild, it can cause severe illness and has a fatality rate of around 1 in 10 people in parts of Africa. There are vaccines and treatments available to prevent and treat monkeypox infections.
Smallpox is a deadly infectious disease caused by the variola virus that was declared eradicated worldwide in 1980 through a global vaccination program. It is characterized by a high fever and distinctive skin rash. While two labs currently house samples of the virus, concerns remain that it could be used in a bioterrorism attack given some countries may still have undeclared stockpiles. The only known effective prevention is vaccination with the vaccinia vaccine within a few days of exposure, though supplies are currently insufficient for a large-scale outbreak.
🔥HOT TOPIC🔥
Sharing my PowerPoint slides on 🐵 MONKEYPOX🐵
(a potential/sure shot question for MD exam)
This can be used for a 2 hour session of PG seminar since all the aspects of the disease are covered.
It includes a compilation of;
1. Infectious history (in detail)
2. Epidemiology (Global, local)
3. Case definitions
4. Clinical features
5. Differential diagnosis (including comparison with common DDs)
6. Complications
7. Investigations
8. Management
9. Vaccines
10. Other specific preventive measures
Share among Community Medicine residents for maximum reach and benefits...😊
Aniket Bide practice school presentation aniketbide
This document provides an overview of monkeypox, including:
1) It describes monkeypox as a rare viral disease caused by infection with the monkeypox virus, with symptoms similar to smallpox but typically milder.
2) Outbreaks of monkeypox have primarily occurred in central and western Africa, though some cases have been reported in other parts of the world through international travel or imported animals.
3) Transmission occurs through direct contact with infected animals like rodents or non-human primates, or close contact between humans.
4) Symptoms include fever, headache, rash, and lesions that may cover the entire body. Most cases resolve within a few weeks
Monkeypox is a zoonotic virus similar to smallpox that is endemic to parts of Africa. It can be transmitted from animals to humans via contact with bodily fluids or consumption of undercooked meat. Human to human transmission is also possible. Symptoms include fever, headache, rash and lesions. There have been increasing outbreaks linked to international travel and exotic pet trade. While there is no proven treatment, isolation and vaccination can help control outbreaks. Prevention requires education on risks, offering PPE, and restricting animal importation.
Monkeypox is derived from the genus Orthopoxvirus from the family Poxividae. This
genus has two kinds of viruses: smallpox and monkeypox virus. Monkeypox is a
zoonotic disease (spread from animal to human or vice versa) and was initially
diagnosed with pox-like symptoms on colonies of monkeys kept for research in 1958,
hence the name monkeypox. At the time of the elimination of smallpox in 1970,
monkeypox in humans was first identified in the Democratic Republic of Congo and
later in Central and Western African countries.1,2 In 2019, a newer vaccinia vaccine
was approved to prevent the disease. Furthermore, investigations are still carried out
on the same.
Animal-to-human (zoonotic) transmission can occur from direct contact with
infected animals' blood, bodily fluids, or cutaneous or mucosal lesions. In Africa,
evidence of monkeypox virus infection has been found in many animals, including
rope squirrels, tree squirrels, Gambian pouched rats, dormice, different species of
monkeys, and others. It was also found that eating improperly/half-cooked meat is
also a cause. The disease spread outside Africa by infected travellers and imported
infected animals. In 2018-2019, cases of monkeypox were confirmed in travellers
from Nigeria, Singapore, the United Kingdom, and Israel. Human-to-human
transmission can result from close contact with respiratory secretions and lesions of
the skin.3
Risk groups include people with severe illnesses who require hospitalization or an
immune-compromised person (HIV, leukaemia, etc); patients with comorbidities, a
pediatric population less than eight years old, and pregnant or breastfeeding women.2
The incubation period is generally 6-13 days, but it can range from 5-21 days. The
disease progression has two phases: The invasive phase (0-5 days), characterized by
headache, fever, back pain, myalgia, fatigue and lymphadenopathy. The rash
appearing phase (1-3 days) begins after the onset of the first phase and is
characterized by the appearance of rashes on the face and then spreads up to the
trunk and limbs of the body. Rashes evolve from macules (flat base lesions) to papules
(firm lesions), then vesicles (clear fluid- filled lesions), and finally postulates
(yellowish fluid-filled lesions) and crusts. It affects the face (in 95% of cases), palms
of the hands, and soles of the feet (in 75% of cases). Also affected were oral mucous
membranes (in 70% of cases), genitalia (30%), conjunctivae (20%), as well as cornea.
Complications of monkeypox include pneumonitis, encephalitis, sight-threatening
keratitis, and secondary bacterial infections.3,4
The document provides an orientation on monkeypox disease. It summarizes that monkeypox is a viral zoonotic disease caused by monkeypox virus. The key symptoms include fever, lymphadenopathy and an acute rash that progresses to papules, vesicles and pustules. It is usually self-limited but can cause complications like secondary infections. Surveillance strategies aim to rapidly identify cases and clusters to isolate cases, manage contacts and implement control measures. Diagnosis is by PCR or sequencing of lesions to detect viral DNA.
Monkeypox is a viral disease that occurs in humans and some animals. It is caused by the monkeypox virus, which belongs to the same family of viruses as smallpox. Monkeypox most commonly spreads through direct contact with infected animals or humans. Initial symptoms include fever, headache, muscle aches, and swollen lymph nodes. Within a few days, a rash develops on the face and spreads to other parts of the body. While monkeypox is generally mild, it can cause severe illness and has a fatality rate of around 1 in 10 people in parts of Africa. There are vaccines and treatments available to prevent and treat monkeypox infections.
Smallpox is a deadly infectious disease caused by the variola virus that was declared eradicated worldwide in 1980 through a global vaccination program. It is characterized by a high fever and distinctive skin rash. While two labs currently house samples of the virus, concerns remain that it could be used in a bioterrorism attack given some countries may still have undeclared stockpiles. The only known effective prevention is vaccination with the vaccinia vaccine within a few days of exposure, though supplies are currently insufficient for a large-scale outbreak.
🔥HOT TOPIC🔥
Sharing my PowerPoint slides on 🐵 MONKEYPOX🐵
(a potential/sure shot question for MD exam)
This can be used for a 2 hour session of PG seminar since all the aspects of the disease are covered.
It includes a compilation of;
1. Infectious history (in detail)
2. Epidemiology (Global, local)
3. Case definitions
4. Clinical features
5. Differential diagnosis (including comparison with common DDs)
6. Complications
7. Investigations
8. Management
9. Vaccines
10. Other specific preventive measures
Share among Community Medicine residents for maximum reach and benefits...😊
Aniket Bide practice school presentation aniketbide
This document provides an overview of monkeypox, including:
1) It describes monkeypox as a rare viral disease caused by infection with the monkeypox virus, with symptoms similar to smallpox but typically milder.
2) Outbreaks of monkeypox have primarily occurred in central and western Africa, though some cases have been reported in other parts of the world through international travel or imported animals.
3) Transmission occurs through direct contact with infected animals like rodents or non-human primates, or close contact between humans.
4) Symptoms include fever, headache, rash, and lesions that may cover the entire body. Most cases resolve within a few weeks
Monkeypox is a zoonotic virus similar to smallpox that is endemic to parts of Africa. It can be transmitted from animals to humans via contact with bodily fluids or consumption of undercooked meat. Human to human transmission is also possible. Symptoms include fever, headache, rash and lesions. There have been increasing outbreaks linked to international travel and exotic pet trade. While there is no proven treatment, isolation and vaccination can help control outbreaks. Prevention requires education on risks, offering PPE, and restricting animal importation.
Monkeypox is derived from the genus Orthopoxvirus from the family Poxividae. This
genus has two kinds of viruses: smallpox and monkeypox virus. Monkeypox is a
zoonotic disease (spread from animal to human or vice versa) and was initially
diagnosed with pox-like symptoms on colonies of monkeys kept for research in 1958,
hence the name monkeypox. At the time of the elimination of smallpox in 1970,
monkeypox in humans was first identified in the Democratic Republic of Congo and
later in Central and Western African countries.1,2 In 2019, a newer vaccinia vaccine
was approved to prevent the disease. Furthermore, investigations are still carried out
on the same.
Animal-to-human (zoonotic) transmission can occur from direct contact with
infected animals' blood, bodily fluids, or cutaneous or mucosal lesions. In Africa,
evidence of monkeypox virus infection has been found in many animals, including
rope squirrels, tree squirrels, Gambian pouched rats, dormice, different species of
monkeys, and others. It was also found that eating improperly/half-cooked meat is
also a cause. The disease spread outside Africa by infected travellers and imported
infected animals. In 2018-2019, cases of monkeypox were confirmed in travellers
from Nigeria, Singapore, the United Kingdom, and Israel. Human-to-human
transmission can result from close contact with respiratory secretions and lesions of
the skin.3
Risk groups include people with severe illnesses who require hospitalization or an
immune-compromised person (HIV, leukaemia, etc); patients with comorbidities, a
pediatric population less than eight years old, and pregnant or breastfeeding women.2
The incubation period is generally 6-13 days, but it can range from 5-21 days. The
disease progression has two phases: The invasive phase (0-5 days), characterized by
headache, fever, back pain, myalgia, fatigue and lymphadenopathy. The rash
appearing phase (1-3 days) begins after the onset of the first phase and is
characterized by the appearance of rashes on the face and then spreads up to the
trunk and limbs of the body. Rashes evolve from macules (flat base lesions) to papules
(firm lesions), then vesicles (clear fluid- filled lesions), and finally postulates
(yellowish fluid-filled lesions) and crusts. It affects the face (in 95% of cases), palms
of the hands, and soles of the feet (in 75% of cases). Also affected were oral mucous
membranes (in 70% of cases), genitalia (30%), conjunctivae (20%), as well as cornea.
Complications of monkeypox include pneumonitis, encephalitis, sight-threatening
keratitis, and secondary bacterial infections.3,4
The document provides an orientation on monkeypox disease. It summarizes that monkeypox is a viral zoonotic disease caused by monkeypox virus. The key symptoms include fever, lymphadenopathy and an acute rash that progresses to papules, vesicles and pustules. It is usually self-limited but can cause complications like secondary infections. Surveillance strategies aim to rapidly identify cases and clusters to isolate cases, manage contacts and implement control measures. Diagnosis is by PCR or sequencing of lesions to detect viral DNA.
Monkeypox is a viral disease that occurs primarily in parts of central and west Africa. It is caused by the monkeypox virus which is transmitted to humans from infected animals or other humans. While less transmissible and fatal than smallpox, monkeypox causes similar symptoms like fever, rash and swollen lymph nodes. It can be diagnosed through PCR, biopsy or blood tests. There are no specific treatments but antivirals developed for smallpox may be used. Prevention involves vaccination, isolation, good hygiene and public health measures.
Here are the key points about smallpox:
- Caused by the variola virus, which only infects humans. There are two variants - variola major which has a higher mortality rate, and variola minor.
- Spread through inhalation of airborne variola virus released from infected individuals. It was estimated that one case of smallpox on average led to 15-20 new cases.
- Symptoms include high fever, fatigue, head and body aches followed by distinctive pustular rash on face/body that leaves scars. Fatality rates for variola major were around 30%.
- There is no cure for smallpox. Prior to the vaccine, variol
This document is a student's outline for a presentation on smallpox. It includes an introduction stating smallpox is a deadly disease caused by the variola virus. It then outlines the causes of smallpox, the different types of smallpox (Variola major and minor), signs and symptoms (fever, rash), diagnosis methods (throat swab, skin sample), treatments (isolation, quarantine), and prevention primarily through vaccination. The last naturally occurring case was in 1977 and WHO declared it eradicated in 1980.
1. The document is a biology project on the Ebola virus completed by a student. It includes an introduction to Ebola, its classification, symptoms, transmission, diagnosis and prevention.
2. The largest sections cover the epidemiology of Ebola, discussing its natural reservoir in fruit bats and outbreaks in West Africa.
3. Treatment of Ebola focuses on treating symptoms and several vaccine candidates are discussed, though none have been approved.
Decoding the Monkeypox Virus : From Discovery to PreventionSindhBiotech
This lecture is presented by our volunteer Sajid Ali Shah, he is from Islamabad, Pakistan, and he is covering the topic Decoding the Monkeypox Virus : From Discovery to Prevention.
For video: https://youtu.be/-RT2UvTerBc
human settlements/communities increased the possibility of a disease infecting many people at a time in a geographical area i.e known as an epidemic. And with time as communities mingled with each other either for trade, war, etc. they spread the diseases to new location fueling the pandemic.
This document provides information on risk assessment and public health management of monkeypox in Malaysia. It discusses the distribution and transmission of monkeypox, clinical presentation and case definitions. Strategies to prevent monkeypox introduction and transmission in Malaysia include strengthening early detection and surveillance, improving diagnostic capabilities, managing cases and contacts, as well as increasing community awareness and preparedness through multisectoral collaboration. Guidelines have been disseminated to international entry points on traveler screening for monkeypox cases in Malaysia.
Zika virus is a mosquito-borne virus first identified in Uganda in 1947. It causes mild fever and rash in most cases but has been linked to Guillain-Barré syndrome and microcephaly. The virus spread out of Africa and Asia, causing major outbreaks in French Polynesia in 2013 and Brazil in 2015. It is transmitted primarily by Aedes mosquitoes. While most cases are mild, the virus can be transmitted from mother to fetus during pregnancy and cause birth defects like microcephaly. There is no vaccine or treatment currently available, so prevention focuses on controlling mosquito populations and protecting against bites.
The document discusses monkeypox, including:
1) It was first identified in monkeys in 1958 and later in humans in 1970. Experts are considering renaming it.
2) It is a double-stranded DNA virus that belongs to the orthopoxvirus genus. There are two clades - Central African and West African.
3) Natural hosts include various squirrel species, Gambian pouched rats, dormice and non-human primates. Further studies are needed to identify the exact reservoir.
The document discusses monkeypox, including:
1) It was first identified in monkeys in 1958 and later in humans in 1970. Experts are considering renaming it.
2) It is a double-stranded DNA virus that belongs to the orthopoxvirus genus. There are two clades - Central African and West African.
3) Natural hosts include various squirrel species, Gambian pouched rats, dormice and non-human primates. Further studies are needed to identify the exact reservoir.
The document provides background information on monkeypox virus, including its transmission between animals and humans, signs and symptoms, diagnosis, treatment and prevention. It discusses the virus's identification in 1970 in the Democratic Republic of Congo and reemergence in Nigeria in 2017. Two genetic clades of the virus are identified, with the Central African clade typically causing more severe illness. Person-to-person transmission is documented. Supportive treatment aims to relieve symptoms and prevent complications. Prevention involves avoiding contact with infected animals or materials and implementing isolation protocols.
Epidemiology is defined as the study of occurrence.docxwrite22
1. Epidemiology is defined as the study of occurrence and distribution of health-related states and events in populations, including determinants that influence these states.
2. Ebola virus disease is a deadly disease caused by Ebolavirus that commonly affects people and primates. It was first discovered in 1976 in the Democratic Republic of Congo and has caused several outbreaks in central and west Africa.
3. The largest Ebola outbreak occurred from 2014-2016 in West Africa, with over 28,000 cases and 11,000 deaths. The outbreak began with an infected child in Guinea and spread to other countries before being contained.
Dengue fever is caused by the dengue virus transmitted by the Aedes mosquito. It has been a major pandemic in the last 50 years, affecting over 100 countries. The document discusses the history, epidemiology, transmission, clinical features, diagnosis and management of dengue fever. It focuses on the situation of dengue in Bangladesh, outlining past outbreaks in the country since 1964 and monthly distribution of cases.
Haramaya university Zika Presentation by Ruach BielMedical Student
This Slide share prepared by Group five.
Department of nursing in Ethiopia that give knowledge about CDC and focus on Zika virus and how to be transmitted and prevent. we wish you good luck.
Haramaya university
prepared
By Ruach Biel Reath
Haramaya university Zika Presentation by Ruach BielMedical Student
this slide is prepared by health care student in ethiopia At haramaya university
College of health and medical science
That can give you good knowledge and how to care for patient who came with zika virus prevention and control.
Haramaya university
Prepared by
Ruach Biel Reath
An overview on Monkeypox, Current Paradigms and Advances in its Vaccination, ...Dr Varruchi Sharma
Monkeypox virus is an orthopoxvirus sharing the common genus with variola and vaccinia virus. Most of the monkeypox (MPX) cases had been reported from the central and west African region (the main endemic areas) prior to 2022 but there was a sudden outbreak in May, 2022 disseminating the infections to thousands of people even in non-endemic countries, posing a global public health emergency. MPX was considered a rae and neglected disease, however the 2022 MPX outbreaks in multiple countries attracted attention of worldwide researchers to pace up for carrying out researches on various aspects of MPXV including attempts to design and develop diagnostics, vaccines, drugs and therapeutics counteract MPX. Apart from being a zoonotic disease, the current outbreaks highlighted rapid human-to-human transmission of MPXV, besides the reverse zoonosis has also been documented with recent first report of human-to-dog transmission, urging a call for the importance of one health approach. Atypical and unusual disease manifestations as well asymptomatic MPXV infections have also been observed during 2022 MPX outbreak. the affected patients typically develop a rash resulting in a mild disease followed by recovery with some supportive care and use of antivirals such as tecovirimat, cidofovir and brincidofovir in severe disease cases. Modified vaccinia Ankara (MVA) vaccine with an excellent safety profile has been recommended to patients with higher risk exposure and immunocompromised individuals. Moreover, another vaccine the replication-competent vaccine (ACAM2000) could be a suitable alternative to MVA’s non-availability to some selective immunocompetent individuals. Current review highlights the salient aspects of management and treatment of monkeypox along with underlying promises in terms of therapeutics and a variety of challenges posed due to current global public health emergency situation to counteract MPX.
This document discusses several emerging and re-emerging infectious diseases including SARS, MERS, Nipah virus, Chikungunya, West Nile virus, Lyme disease, Kyasanur forest disease. It provides details on the causative agents, modes of transmission, symptoms, treatment and prevention measures for each disease. It also discusses definitions of emerging and re-emerging diseases and factors responsible for their emergence or re-emergence such as rapid population growth, international travel, antibiotic resistance.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
ZIKA VIRUS Sensitization for Faculty and students by Department Of Medicine S...SMS MEDICAL COLLEGE
The current outbreak of Zika virus in Jaipur, India has rekindled national and international interest in this mosquito-borne illness. Zika virus causes a mild fever but can also result in serious neurological complications like Guillain-Barré syndrome and microcephaly in infants born to infected mothers. While the illness is usually self-limiting, the recent outbreak in Jaipur of 29 reported cases in one month requires a task force to prevent further spread.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Monkeypox is a viral disease that occurs primarily in parts of central and west Africa. It is caused by the monkeypox virus which is transmitted to humans from infected animals or other humans. While less transmissible and fatal than smallpox, monkeypox causes similar symptoms like fever, rash and swollen lymph nodes. It can be diagnosed through PCR, biopsy or blood tests. There are no specific treatments but antivirals developed for smallpox may be used. Prevention involves vaccination, isolation, good hygiene and public health measures.
Here are the key points about smallpox:
- Caused by the variola virus, which only infects humans. There are two variants - variola major which has a higher mortality rate, and variola minor.
- Spread through inhalation of airborne variola virus released from infected individuals. It was estimated that one case of smallpox on average led to 15-20 new cases.
- Symptoms include high fever, fatigue, head and body aches followed by distinctive pustular rash on face/body that leaves scars. Fatality rates for variola major were around 30%.
- There is no cure for smallpox. Prior to the vaccine, variol
This document is a student's outline for a presentation on smallpox. It includes an introduction stating smallpox is a deadly disease caused by the variola virus. It then outlines the causes of smallpox, the different types of smallpox (Variola major and minor), signs and symptoms (fever, rash), diagnosis methods (throat swab, skin sample), treatments (isolation, quarantine), and prevention primarily through vaccination. The last naturally occurring case was in 1977 and WHO declared it eradicated in 1980.
1. The document is a biology project on the Ebola virus completed by a student. It includes an introduction to Ebola, its classification, symptoms, transmission, diagnosis and prevention.
2. The largest sections cover the epidemiology of Ebola, discussing its natural reservoir in fruit bats and outbreaks in West Africa.
3. Treatment of Ebola focuses on treating symptoms and several vaccine candidates are discussed, though none have been approved.
Decoding the Monkeypox Virus : From Discovery to PreventionSindhBiotech
This lecture is presented by our volunteer Sajid Ali Shah, he is from Islamabad, Pakistan, and he is covering the topic Decoding the Monkeypox Virus : From Discovery to Prevention.
For video: https://youtu.be/-RT2UvTerBc
human settlements/communities increased the possibility of a disease infecting many people at a time in a geographical area i.e known as an epidemic. And with time as communities mingled with each other either for trade, war, etc. they spread the diseases to new location fueling the pandemic.
This document provides information on risk assessment and public health management of monkeypox in Malaysia. It discusses the distribution and transmission of monkeypox, clinical presentation and case definitions. Strategies to prevent monkeypox introduction and transmission in Malaysia include strengthening early detection and surveillance, improving diagnostic capabilities, managing cases and contacts, as well as increasing community awareness and preparedness through multisectoral collaboration. Guidelines have been disseminated to international entry points on traveler screening for monkeypox cases in Malaysia.
Zika virus is a mosquito-borne virus first identified in Uganda in 1947. It causes mild fever and rash in most cases but has been linked to Guillain-Barré syndrome and microcephaly. The virus spread out of Africa and Asia, causing major outbreaks in French Polynesia in 2013 and Brazil in 2015. It is transmitted primarily by Aedes mosquitoes. While most cases are mild, the virus can be transmitted from mother to fetus during pregnancy and cause birth defects like microcephaly. There is no vaccine or treatment currently available, so prevention focuses on controlling mosquito populations and protecting against bites.
The document discusses monkeypox, including:
1) It was first identified in monkeys in 1958 and later in humans in 1970. Experts are considering renaming it.
2) It is a double-stranded DNA virus that belongs to the orthopoxvirus genus. There are two clades - Central African and West African.
3) Natural hosts include various squirrel species, Gambian pouched rats, dormice and non-human primates. Further studies are needed to identify the exact reservoir.
The document discusses monkeypox, including:
1) It was first identified in monkeys in 1958 and later in humans in 1970. Experts are considering renaming it.
2) It is a double-stranded DNA virus that belongs to the orthopoxvirus genus. There are two clades - Central African and West African.
3) Natural hosts include various squirrel species, Gambian pouched rats, dormice and non-human primates. Further studies are needed to identify the exact reservoir.
The document provides background information on monkeypox virus, including its transmission between animals and humans, signs and symptoms, diagnosis, treatment and prevention. It discusses the virus's identification in 1970 in the Democratic Republic of Congo and reemergence in Nigeria in 2017. Two genetic clades of the virus are identified, with the Central African clade typically causing more severe illness. Person-to-person transmission is documented. Supportive treatment aims to relieve symptoms and prevent complications. Prevention involves avoiding contact with infected animals or materials and implementing isolation protocols.
Epidemiology is defined as the study of occurrence.docxwrite22
1. Epidemiology is defined as the study of occurrence and distribution of health-related states and events in populations, including determinants that influence these states.
2. Ebola virus disease is a deadly disease caused by Ebolavirus that commonly affects people and primates. It was first discovered in 1976 in the Democratic Republic of Congo and has caused several outbreaks in central and west Africa.
3. The largest Ebola outbreak occurred from 2014-2016 in West Africa, with over 28,000 cases and 11,000 deaths. The outbreak began with an infected child in Guinea and spread to other countries before being contained.
Dengue fever is caused by the dengue virus transmitted by the Aedes mosquito. It has been a major pandemic in the last 50 years, affecting over 100 countries. The document discusses the history, epidemiology, transmission, clinical features, diagnosis and management of dengue fever. It focuses on the situation of dengue in Bangladesh, outlining past outbreaks in the country since 1964 and monthly distribution of cases.
Haramaya university Zika Presentation by Ruach BielMedical Student
This Slide share prepared by Group five.
Department of nursing in Ethiopia that give knowledge about CDC and focus on Zika virus and how to be transmitted and prevent. we wish you good luck.
Haramaya university
prepared
By Ruach Biel Reath
Haramaya university Zika Presentation by Ruach BielMedical Student
this slide is prepared by health care student in ethiopia At haramaya university
College of health and medical science
That can give you good knowledge and how to care for patient who came with zika virus prevention and control.
Haramaya university
Prepared by
Ruach Biel Reath
An overview on Monkeypox, Current Paradigms and Advances in its Vaccination, ...Dr Varruchi Sharma
Monkeypox virus is an orthopoxvirus sharing the common genus with variola and vaccinia virus. Most of the monkeypox (MPX) cases had been reported from the central and west African region (the main endemic areas) prior to 2022 but there was a sudden outbreak in May, 2022 disseminating the infections to thousands of people even in non-endemic countries, posing a global public health emergency. MPX was considered a rae and neglected disease, however the 2022 MPX outbreaks in multiple countries attracted attention of worldwide researchers to pace up for carrying out researches on various aspects of MPXV including attempts to design and develop diagnostics, vaccines, drugs and therapeutics counteract MPX. Apart from being a zoonotic disease, the current outbreaks highlighted rapid human-to-human transmission of MPXV, besides the reverse zoonosis has also been documented with recent first report of human-to-dog transmission, urging a call for the importance of one health approach. Atypical and unusual disease manifestations as well asymptomatic MPXV infections have also been observed during 2022 MPX outbreak. the affected patients typically develop a rash resulting in a mild disease followed by recovery with some supportive care and use of antivirals such as tecovirimat, cidofovir and brincidofovir in severe disease cases. Modified vaccinia Ankara (MVA) vaccine with an excellent safety profile has been recommended to patients with higher risk exposure and immunocompromised individuals. Moreover, another vaccine the replication-competent vaccine (ACAM2000) could be a suitable alternative to MVA’s non-availability to some selective immunocompetent individuals. Current review highlights the salient aspects of management and treatment of monkeypox along with underlying promises in terms of therapeutics and a variety of challenges posed due to current global public health emergency situation to counteract MPX.
This document discusses several emerging and re-emerging infectious diseases including SARS, MERS, Nipah virus, Chikungunya, West Nile virus, Lyme disease, Kyasanur forest disease. It provides details on the causative agents, modes of transmission, symptoms, treatment and prevention measures for each disease. It also discusses definitions of emerging and re-emerging diseases and factors responsible for their emergence or re-emergence such as rapid population growth, international travel, antibiotic resistance.
Zika virus disease is a mosquito-borne viral infection that primarily occurs in tropical and subtropical areas of the world.
It is related to other pathogenic vector borne flaviviruses including dengue, West-Nile and Japanese encephalitis viruses but produces a comparatively mild disease in humans
Genre: Flavivirus
Vector: Aedes mosquitoes (which usually bite during the morning and late afternoon/evening hours)
Reservoir: mosquitoes (gut, blood, saliva )
human ( blood, prostate, semen and testes )
ZIKA VIRUS Sensitization for Faculty and students by Department Of Medicine S...SMS MEDICAL COLLEGE
The current outbreak of Zika virus in Jaipur, India has rekindled national and international interest in this mosquito-borne illness. Zika virus causes a mild fever but can also result in serious neurological complications like Guillain-Barré syndrome and microcephaly in infants born to infected mothers. While the illness is usually self-limiting, the recent outbreak in Jaipur of 29 reported cases in one month requires a task force to prevent further spread.
How to Implement a Strategy: Transform Your Strategy with BSC Designer's Comp...Aleksey Savkin
The Strategy Implementation System offers a structured approach to translating stakeholder needs into actionable strategies using high-level and low-level scorecards. It involves stakeholder analysis, strategy decomposition, adoption of strategic frameworks like Balanced Scorecard or OKR, and alignment of goals, initiatives, and KPIs.
Key Components:
- Stakeholder Analysis
- Strategy Decomposition
- Adoption of Business Frameworks
- Goal Setting
- Initiatives and Action Plans
- KPIs and Performance Metrics
- Learning and Adaptation
- Alignment and Cascading of Scorecards
Benefits:
- Systematic strategy formulation and execution.
- Framework flexibility and automation.
- Enhanced alignment and strategic focus across the organization.
Discover timeless style with the 2022 Vintage Roman Numerals Men's Ring. Crafted from premium stainless steel, this 6mm wide ring embodies elegance and durability. Perfect as a gift, it seamlessly blends classic Roman numeral detailing with modern sophistication, making it an ideal accessory for any occasion.
https://rb.gy/usj1a2
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
3 Simple Steps To Buy Verified Payoneer Account In 2024SEOSMMEARTH
Buy Verified Payoneer Account: Quick and Secure Way to Receive Payments
Buy Verified Payoneer Account With 100% secure documents, [ USA, UK, CA ]. Are you looking for a reliable and safe way to receive payments online? Then you need buy verified Payoneer account ! Payoneer is a global payment platform that allows businesses and individuals to send and receive money in over 200 countries.
If You Want To More Information just Contact Now:
Skype: SEOSMMEARTH
Telegram: @seosmmearth
Gmail: seosmmearth@gmail.com
SATTA MATKA SATTA FAST RESULT KALYAN TOP MATKA RESULT KALYAN SATTA MATKA FAST RESULT MILAN RATAN RAJDHANI MAIN BAZAR MATKA FAST TIPS RESULT MATKA CHART JODI CHART PANEL CHART FREE FIX GAME SATTAMATKA ! MATKA MOBI SATTA 143 spboss.in TOP NO1 RESULT FULL RATE MATKA ONLINE GAME PLAY BY APP SPBOSS
Part 2 Deep Dive: Navigating the 2024 Slowdownjeffkluth1
Introduction
The global retail industry has weathered numerous storms, with the financial crisis of 2008 serving as a poignant reminder of the sector's resilience and adaptability. However, as we navigate the complex landscape of 2024, retailers face a unique set of challenges that demand innovative strategies and a fundamental shift in mindset. This white paper contrasts the impact of the 2008 recession on the retail sector with the current headwinds retailers are grappling with, while offering a comprehensive roadmap for success in this new paradigm.
Top mailing list providers in the USA.pptxJeremyPeirce1
Discover the top mailing list providers in the USA, offering targeted lists, segmentation, and analytics to optimize your marketing campaigns and drive engagement.
The 10 Most Influential Leaders Guiding Corporate Evolution, 2024.pdfthesiliconleaders
In the recent edition, The 10 Most Influential Leaders Guiding Corporate Evolution, 2024, The Silicon Leaders magazine gladly features Dejan Štancer, President of the Global Chamber of Business Leaders (GCBL), along with other leaders.
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Final ank Satta Matka Dpbos Final ank Satta Matta Matka 143 Kalyan Matka Guessing Final Matka Final ank Today Matka 420 Satta Batta Satta 143 Kalyan Chart Main Bazar Chart vip Matka Guessing Dpboss 143 Guessing Kalyan night
Building Your Employer Brand with Social MediaLuanWise
Presented at The Global HR Summit, 6th June 2024
In this keynote, Luan Wise will provide invaluable insights to elevate your employer brand on social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok. You'll learn how compelling content can authentically showcase your company culture, values, and employee experiences to support your talent acquisition and retention objectives. Additionally, you'll understand the power of employee advocacy to amplify reach and engagement – helping to position your organization as an employer of choice in today's competitive talent landscape.
Taurus Zodiac Sign: Unveiling the Traits, Dates, and Horoscope Insights of th...my Pandit
Dive into the steadfast world of the Taurus Zodiac Sign. Discover the grounded, stable, and logical nature of Taurus individuals, and explore their key personality traits, important dates, and horoscope insights. Learn how the determination and patience of the Taurus sign make them the rock-steady achievers and anchors of the zodiac.
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Tastemy Pandit
Know what your zodiac sign says about your taste in food! Explore how the 12 zodiac signs influence your culinary preferences with insights from MyPandit. Dive into astrology and flavors!
At Techbox Square, in Singapore, we're not just creative web designers and developers, we're the driving force behind your brand identity. Contact us today.
1. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
268
A REVIEW OF THE MONKEYPOX OUTBREAK IN INDONESIA IN 2022
Meiriani Sari1*
, Nany Hairunisa2
1
Department of Pediatrics, Faculty of Medicine,Universitas Trisakti, Jakarta, Indonesia
2
Department of Occupational Medicine, Faculty of Medicine, Universitas Trisakti, Jakarta. Indonesia
* Corresponding Author : E-mail : Meiriani_sari@trisakti.ac.id
ABSTRACT
Monkeypox disease (monkey smallpox) is a disease that has never been found in Indonesia since it was first discovered in
humans in the Congo in 1970. So if there is one positive confirmed event, then the disease is an Extraordinary Event
(KLB). This disease has become a global concern because since May 13, 2022, WHO has received reports of Monkeypox
cases from non-endemic countries. It has expanded to 4 WHO regions: Europe, America, Eastern Mediterranean, and
Western Pacific. Until now, further investigations and studies are still being carried out to understand more about the
epidemiology, sources of infection, and transmission patterns in non-endemic countries that have reported new cases, such
as Indonesia. Until now, no specific treatment has been proven to treat Monkeypox infection. Currently, the therapy used
is symptomatic support. The antiviral tecovirimat, or TPOXX, developed by the European Medicines Agency (EMA) as a
Monkeypox therapy in 2022 based on research, has not been marketed freely. In addition, antivirals such as cidofovir and
brincidofovir have been shown to be effective against orthopox virus in vitro and in animal studies. However, the
effectiveness of this drug against monkeypox in humans is not yet known. However, this disease can be prevented by
vaccination. In Indonesia, the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is recommended to prevent
Monkeypox disease. The existence of the outbreak report is important to discuss, explore, and understand more about the
disease and its management and prevention.
Keywords: Antivirus, Outbreaks, Monkeypox, Vaccination
INTRODUCTION
Monkeypox disease has never been found in
Indonesia since it was first discovered in humans in
the Congo in 1970, caused by the Monkeypox virus.
On August 19th
, 2022, one positive case was found in
a 27-year-old male patient in Jakarta. As of
September 15th
, 2022, 2 suspects and 63 were
discarded. From the distribution of 63 patients with
discarded status covering ten provinces in Indonesia.1
Monkeypox itself was first discovered in
1958 when an outbreak of diseases such as smallpox
occurred in a group of monkeys that were kept for
research.2,3,4
Common symptoms such as fever,
headache, enlarged lymph nodes, and skin lesions
can cause severe pain.5
This disease has clinical
relevance in endemic areas of Africa, with outbreaks
in the west due to international travel. 6
According to the WHO, around 3-6% of
cases can be fatal; unfortunately, the data on deaths
based on cases in Africa before 2022 do not have
data that is too representative. Monkeypox virus can
heal itself without getting special treatment within a
few weeks. As of August 2, 2022, 80 countries have
reported approximately 24,000 cases of Monkeypox
and five deaths have occurred since May 2022.
Monkeypox has since become a disease of global
public health concern, as it was reported in
previously non-endemic countries. Since May 13,
2022, WHO has received reports of Monkeypox
cases originating from non-endemic countries, and
currently, it has expanded to 4 WHO regions, namely
Europe, America, Eastern Mediterranean, and
Western Pacific. 7–10
Until now, further investigations and studies
are still being carried out to understand better the
epidemiology, sources of infection, and transmission
patterns in non-endemic countries that have reported
new cases, such as Indonesia. There are reports of
human-to-human transmission, considering the
importance of cases in infected countries. In addition
to the possibility of infectious animals in Indonesia,
it is important to discuss, explore, and understand
how to deal with this disease.1,2
About Monkeypox
Monkeypox is a rare zoonotic disease caused
by the Monkeypox virus.3
This virus is in the same
family as viruses such as the variola virus that causes
smallpox. Monkeypox virus contains double-
stranded DNA and has a 200-250 nm brick-shaped
envelope. This virus belongs to Poxviridae,
subfamily Chordopoxvirinae, and genus
Orthopoxvirus. Monkeypox symptoms are similar to
those of smallpox but are usually milder. Although
named Monkeypox, the main cause of this disease is
not known with certainty. However, African rodents
and primates (such as monkeys) may harbor the virus
and transmit it to humans.3,11–16
2. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
269
Figure 1. Some forms of Monkeypox virus1
Epidemiology and Risk Factors (Vulnerable
Group)
Fatal cases of Monkeypox are more common
in children and are often related to exposure to the
virus, the patient's health status and complications.
The presence of immune deficiency can worsen the
prognosis. Smallpox vaccination can reduce the
incidence of this disease. Individuals under 40-50
years old seem more easily infected with
Monkeypox. This is thought to occur due to the
decreasing number of smallpox vaccines as the
disease is eradicated in several countries. 9,12,14,17,18
Some groups included in the vulnerable group
are pregnant women, children, and
immunocompromised patients. Research conducted
by the New England Journal of Medicine recently
showed that 98% of monkeypox cases diagnosed in
16 countries between April and June occurred in men
who had sex with other men. This raises concerns
about the stigma of the LGBT community toward
Monkeypox.19,20
Transmission
Monkeypox is usually passed from person to
person through close contact with an infected person.
Contact from person to person, such as direct contact,
contact with droplets, contact with infectious body
fluids or through media (linen). The virus enters the
body through broken/open skin (even if it is not
visible), the respiratory tract, or mucous membranes
(eyes, nose, or mouth). Airborne transmission is rare.
Transmission through droplets usually requires
prolonged contact, so family members who live in
the same household or are in close contact with cases
are at greater risk of infection. People with
Monkeypox are contagious when symptomatic
(usually between two to four weeks). Rashes, body
fluids (such as fluid, pus or blood from skin lesions)
and scabs are highly contagious. Clothes, bedding,
towels or eating utensils/plates contaminated with the
virus from an infected person can also infect others.14
In addition, animal-to-person transmission
can also occur. Contact with blood, body fluids or
skin lesions of infected animals can transmit
Monkeypox. Monkeypox's natural reservoir has not
been determined, but it is most likely in rodents.
Monkeypox infection in Africa has been found in
many animal species: tree squirrels, Gambian giant
rats, striped rats, dormice and primates. In the case
that occurred in the United States, the first case was
infected by a prairie dog. 4,21,22
Pathophysiology
The entry of the virus from various places of
entry, such as the oropharynx, nasopharynx and
intradermal; Monkeypox virus will then replicate at
the inoculation site and then spread through the
lymph nodes. Initial viremia will trigger the viral
spread of the infection and focus on other organs.
This phase describes the incubation period. This
period lasts 7-14 days with a deadline of 21 days.
The onset of symptoms correlates with secondary
viremia lasting 1-2 days of prodromal symptoms
such as fever and lymphadenopathy before the
appearance of the lesions. Infected patients are highly
contagious during this period. Lesions begin in the
oropharynx and then on the skin. Serum antibodies
can be detected when lesions appear. 2,4,5,9,12
Sign and Symptoms
Monkeypox symptoms vary. Some people can
have moderate symptoms, while some can be more
severe and require health facilities. The most
common symptoms include fever, headache,
myalgia, backache, malaise and enlarged lymph
nodes. These symptoms can be followed or
accompanied by a rash lasting two to three weeks.23
This rash is commonly found on the face,
palms, soles of the feet, eyes, mouth, throat, and
genital areas such as the penis, vulva, and anus. The
number of these rash lesions varies from one to
thousands. The evolution of these lesions usually
begins with the appearance of macular lesions and
then becomes papules, vesicular, pustular to
desquamated. These lesions are usually firm and
often form an umbilical cord (a point at the apex of
the lesion). These lesions are typically painful to the
point that they become itchy during the healing
process. The patient will remain infectious until all
lesions heal.1,3,5,7,12,14,23,24
3. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
270
Figure 2. Lesions on Monkeypox 1
In addition, Monkeypox can also be
accompanied by rectal symptoms. Purulent or bloody
stools, rectal pain or bleeding from the rectum may
be seen in patients with Monkeypox. Respiratory
symptoms such as sore throat, nasal congestion, and
cough can be found in sufferers.1,2,8
Monkeypox infection can be divided into
two periods:2
The invasion period (lasting 0-5 days)
is characterized by fever, severe headache,
lymphadenopathy, back pain, myalgia, and severe
asthenia. Lymphadenopathy is a distinctive feature of
Monkeypox compared to similar diseases.
Lymphadenopathy can be felt in the neck, armpit or
groin.2
The skin eruption usually begins within 1-3
days of the onset of fever. The rash tends to appear
on the face and extremities rather than the trunk.
Involves the face in 95% of cases, palms and soles in
75% of cases, genitalia in 30% of cases and the
conjunctiva in 20% of cases, including the cornea.
Lesions develop from macules to papules then
vesicles and pustules to crust over and detach from
the skin. The number of lesions varies from a few to
several thousand. In severe cases, the lesions may
coalesce and cause large patches of skin to peel.1,2,8
Table 1. Monkeypox lesion progression2
Stadium Duration Characteristic
Enatem Lesions sometimes appear first on
the tongue and in the mouth
Macula 1-2 days Macular lesions appear
Papule 1-2 days The lesion progresses from a
macula (flat) to a papule (there is
an elevation)
Vesicle 1-2 days The lesion will become a vesicle,
an elevated lesion with elevation
and filled with clear fluid
Pustule 5-7 days The lesion becomes a pustule
filled with opaque fluid, elevates,
is round and hard on pressure
Crust 7-14 days At the end of the second week,
the pustules become crusty and
will last up to 1 week and then
peel off
4. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
271
Figure 3. Clinical Manifestations in Monkeypox2
Diagnosis and Differential Diagnosis
In addition to signs and symptoms,
Monkeypox's diagnosis is based on real-time
polymerase chain reaction (PCR) examination of dry
swab samples of lesions or ulcers. Samples from
nasopharyngeal swabs, serum samples, scabs, and
tissue samples can also be used for PCR or
pathological examination. The differential diagnosis
includes syphilis, cancroid, varicella zoster, herpes
simplex, hand-foot-and-mouth disease, molluscum
contagious and cryptococcus. 1,3,5,6,8,12,14
The definition of Monkeypox cases can be
divided into four classifications of suspected
(suspected), confirmed, probable and possible
diagnoses. The Monkeypox case definitions are
divided into four classifications: suspected,
confirmed, probable and possible diagnoses.
Suspected cases are patients with sudden onset of
fever followed by vesicular-pustular eruptions
predominantly on the face, palms, soles of the feet,
and the discovery of at least five smallpox-type
crusts. Recent WHO guidelines add the presence of a
mucosal lesion as the definition of a suspected case.
Confirmed cases are suspected cases that have been
confirmed by the laboratory, such as positive IgA
antibodies, PCR or virus isolation. A probable case is
a suspected case with appropriate epidemiology but
no laboratory confirmation access. Cases may be
established in patients with vesicular lesions,
pustules or crusts who have not been diagnosed with
measles, have a history of fever with vesicles or have
a crusted rash. This individual also meets
epidemiological criteria, has an orthopoxvirus-
specific IgM elevation, and has an unexplained
febrile rash. 1,3,5,6,8,12,14
Clinically, Monkeypox's differential
diagnosis can account for diseases with other rashes,
such as smallpox, chickenpox, measles, bacterial skin
infections, scabies, syphilis, and specific drug-related
allergies. In addition, lymphadenopathy during the
prodromal phase can be a typical clinical feature to
distinguish Monkeypox from other similar smallpox
diseases, such as smallpox, chickenpox/varicella
(chickenpox), and others.8
Figure 4. Lymphadenopathy in children with monkeypox8
Table 2. Comparison of Monkeypox Symptoms and Signs
and Differential Diagnosis2
Symptoms
and Signs
Monkeypox Chickenpox
(Varicella)
Measles
Fever Fever >38°C,
rash after 1-3
days
Fever up to
39°C, rash
after 0-2 days
High fever
40.5°C, rash
after 2-4 days
Rash Macules,
papules,
vesicles,
pustules. The
type of rash is
the same in
every phase in
all areas of
the body
Macules,
papules,
vesicles.
There are
various
phases
Non-vesicular
rash in
various
phases
Rash
development
Slow, 3-4
weeks
Fast, crops
appear for a
few days
Fast, 5-7 days
5. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
272
Rash
Duration
Starting at the
head, denser
on the face
and limbs;
appears on the
palms of the
hands and
soles of the
feet
Start at the
head; denser
on the body;
not on the
palms of the
hands and
soles of the
feet
Starts in the
head and
spreads; can
reach hands
and feet
Distinctive
appearance
Lymphadenop
athy
Itchy rash Koplik spots
Mortality 3-6% Rare Varies
2022 Monkeypox Outbreak
Monkeypox was first discovered in 1958
when a disease such as the smallpox outbreak
occurred in a group of Singaporean monkeys sent to
Denmark for research. The first human case of
Monkeypox was discovered in 1970 in Congo in a 9-
month-old child. As of June 2022, 86% of cases
reported to WHO were from the European region.
Other regions such as Africa 2%, America 11%,
Eastern Mediterranean <1%, and West Pacific region
<1%.3,5,8–14
Since May 2022, Monkeypox cases have been
reported from non-endemic countries and forwarded
to reports from endemic countries. Most confirmed
cases had a history of travelling to European and
North American countries, compared to Central and
South Africa, where Monkeypox is endemic. This is
the first time that Monkeypox cases have been found
in both endemic and non-endemic countries. Of the
cases reported to WHO, most were identified as
being transmitted through sexual intercourse or
health facilities related to but not exclusively with
men who have sex with men.2,4,8,17,20,22
On August 19, 2022, one positive case was
found in a 27-year-old male patient in Jakarta. As of
September 15, 2022, there are 2 suspects and 63
discarded. From the distribution of 63 patients with
discarded status covering 10 provinces in Indonesia.1
Management and Vaccination
Currently, no specific treatment has been
proven to treat Monkeypox infection. Like other viral
diseases, Monkeypox therapy is symptomatic
supportive therapy. An antiviral tecovirimat or
TPOXX was developed by the European Medicines
Agency (EMA) as a monkeypox therapy in 2022
based on animal and human studies. This drug has
not been marketed freely. In addition, antivirals such
as cidofovir and brincidofovir have been shown to be
effective against orthopoxvirus in in-vitro and animal
studies. The effectiveness of this drug against
monkeypox in humans is unknown. 2,3,5,8,24–26
However, there are also precautions that can
be taken to prevent an outbreak from occurring. For
example, vaccines used during smallpox (smallpox)
eradication programs protect{ }Monkeypox. Based
on several observational studies, the smallpox
vaccine has an effectiveness of 85% for preventing
Monkeypox. In addition, receiving this vaccine will
result in milder symptoms. A new vaccine developed
for smallpox was approved in 2019 to prevent
Monkeypox, but global availability is limited.2,8,27–29
The recommended vaccination in Indonesia
to reduce the incidence of Monkeypox is the
Modified Vaccinia Ankara-Bavarian Nordic (MVA-
BN) vaccine. The MVA-BN that will be used as the
third generation of smallpox vaccine is effective and
safe to give to monkeypox patients with
immunocompromised conditions or those with innate
immune disorders. In addition, MVA-BN is also safe
to use for patients over 18 years, children and also
pregnant woman. , .1,2
Complications and Prognosis
There are data on the relationship between
Monkeypox in children. However, based on reports
of patients infected with Monkeypox, this disease
tends to be more severe in children. Rarely,
Monkeypox can cause complications, including
encephalitis, cellulitis, pneumonia, sepsis, abscess,
airway obstruction due to severe lymphadenopathy,
keratitis, hyperpigmentation, pneumonia, and corneal
scarring. 2,8,30,31
Conclusions
With the outbreak report, it is important to
discuss, explore, and understand more about the
disease and its management and prevention.
Unfortunately, there is currently no specific
treatment for Monkeypox. However, this disease can
be prevented by vaccination. In Indonesia, the
Modified Vaccinia Ankara-Bavarian Nordic (MVA-
BN) vaccine is recommended to prevent Monkeypox
disease.
CONFLICTS OF INTEREST
The authors declare no conflict of interest in
this article.
FUNDING
No specific funding was provided for this
review.
6. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
273
AUTHORS CONTRIBUTIONS
The authors contributions to this review are
as follows: conceptualization, collecting literature,
and writing draft: Meiriani Sari; supervision, review
and editing: Nany Hairunisa.
REFERENCES
1. Kementerian Kesehatan Republik Indonesia.
Kasus Monkeypox Pertama di Indonesia
Terkonfirmasi. 2022.
2. Pedoman Pencegahan dan Pengendalian
Kementerian Kesehatan RI Direktorat
Jenderal dan Pengendalian Penyakit.
Pedoman Pencegahan dan Pengendalian
Penyakit Monkeypox. Kementerian
Kesehatan. 2022.
3. Singhal T, Kabra SK, Lodha R. Monkeypox:
A Review. Indian J Pediatr. 2022
Oct;89(10):955–60.
4. Nolen LD, Osadebe L, Katomba J, Likofata J,
Mukadi D, Monroe B, et al. Extended human-
to-human transmission during a monkeypox
outbreak in the Democratic Republic of the
Congo. Emerg Infect Dis. 2016 Jun
1;22(6):1014–21.
5. Cheema AY, Ogedegbe OJ, Munir M, Alugba
G, Ojo TK. Monkeypox: A Review of
Clinical Features, Diagnosis, and Treatment.
Cureus. 2022 Jul 11;
6. Velevan TP, Meyer CG. Monkeypox 2022
outbreak An update. Trop Med Int Health.
2022;27:604–5.
7. Hraib M, Jouni S, Albitar MM, Alaidi S,
Alshehabi Z. The outbreak of monkeypox
2022: An overview. Annals of Medicine and
Surgery. 2022 Jul 1;79(104069):1–4.
8. Centers for Disease Control and Prevention.
Monkeypox Signs and Symptoms. 2022.
9. Beer EM, Bhargavi Rao V. A systematic
review of the epidemiology of human
monkeypox outbreaks and implications for
outbreak strategy. PLoS Negl Trop Dis.
2019;13(10).
10. European Centre for Disease Prevention and
Control. Monkeypox multi-country outbreak
Key messages. 2022.
11. Oladoye MJ. Monkeypox: A Neglected Viral
Zoonotic Disease. European Journal of
Medical and Educational Technologies. 2021
May 15;14(2):em2108.
12. Petersen E, Kantele A, Koopmans M, et al.
Human Monkeypox epidemiologic and
clinical characteristic, diagnosis and
prevention Elsevier Enhanced Reader. Infect
Dis Clin An Am. 2019;33:1027–43.
13. Kapoor S, Varadharajan A. Monkeypox 2022:
Emerging Zoonotic Epidemic Threat, Future
Implications, and Way Ahead. Journal of
Public Health and Primary Care.
2022;20(20):1–4.
14. Pal M, Mengstie F, Kandi V. Epidemiology,
Diagnosis, and Control of Monkeypox
Disease: A comprehensive Review. American
Journal of Infectious Diseases and
Microbiology. 2017;5(2):94–9.
15. Centre for Emerging Zoonotik and Parasitic
Diseases Outbreak Response Unit D of PHS
and R. Monkeypox Frequently Asked
Questions. 2022.
16. Moore MJ, Rathis B, Zahra F. Monkeypox.
In: Abai A, Abu-Gosh A, Acharya AB,
editors. StatPeals. 4th ed. 2022. p. 1–4.
17. Reardon S. Why is Monkeypox Evolving So
Fast - Scientific American. Scientific
AnAmerican. 2022. p. 1–2.
18. Bunge EM, Hoet B, Chen L, Lienert F,
Weidenthaler H, Baer LR, et al. The changing
epidemiology of human monkeypox—A
potential threat? A systematic review. PLoS
Negl Trop Dis. 2022 Feb 1;16(2).
19. Thornhill JP, Barkati S, Walmsley S,
Rockstroh J, Antinori A, Harrison LB, et al.
Monkeypox Virus Infection in Humans across
16 Countries — April–June 2022. New
England Journal of Medicine. 2022 Aug
25;387(8):679–91.
20. Orkin C. Monkeypox an expert explains what
gay and bisexual men need to know. The
Conversation. 2022.
21. Hutson CL, Carroll DS, Gallardo-Romero N,
Drew C, Zaki SR, Nagy T, et al. Comparison
of Monkeypox Virus Clade Kinetics and
Pathology within the Prairie Dog Animal
Model Using a Serial Sacrifice Study Design.
Biomed Res Int. 2015;2015:1–19.
22. Grant R, Nguyen LBL, Breban R. Modelling
human-to-human transmission of monkeypox.
Bulletin of the World Health Organization.
2020 Sep 1;98(9):638–40.
23. Patel A, Bilinska J, Tam JCH, da Silva
Fontoura D, Mason CY, Daunt A, et al.
Clinical features and novel presentations of
human monkeypox in a central London centre
7. JURNAL KEDOKTERAN DIPONEGORO
Online : http://ejournal3.undip.ac.id/index.php/medico
E-ISSN : 2540-8844
JKD, Volume 11, Nomor 5, September 2022
Meiriani Sari, Nany Hairunisa
274
during the 2022 outbreak: Descriptive case
series. The BMJ. 2022;378(e072410):1–17.
24. Adler H, Gould S, Hine P, et.al. Clinical
features and management of human
monkeypox a retrospective observational
study in the UK - PubMed. The Lancet Dis.
2022;8:1153–62.
25. Reynolds MG, McCollum AM, Nguete B,
Lushima RS, Petersen BW. Improving the
care and treatment of monkeypox patients in
low-resource settings: Applying evidence
from contemporary biomedical and smallpox
biodefense research. Viruses. 2017 Dec
12;9(380):1–14.
26. Johnson PLF, Bergstrom CT, Regoes RR,
Longini IM, Halloran ME, Antia R.
Evolutionary consequences of delaying
intervention for monkeypox. The Lancet.
2022 Sep;1–2.
27. Brooks JT, Marks P, Goldstein RH, Walensky
RP. Intradermal Vaccination for Monkeypox
— Benefits for Individual and Public Health.
New England Journal of Medicine. 2022 Aug
31;1–3.
28. Gruber MF. Current status of monkeypox
vaccines. NPJ Vaccines. 2022 Aug
17;7(94):1–3.
29. Thy M, Peiffer-Smadja N, Mailhe M, Kramer
L, Ferré VM, Houhou-Fidouh N, et al.
Breakthrough infections after post-exposure
vaccination against Monkeypox. medrxiv.
2022 Aug 4;1–19.
30. Billioux B.J, Tshiani O, Sejvar J. Neurologic
Complications of Smallpox and Monkeypox
A Review Infectious Diseases JAMA
Neurology JAMA Network. JAMA Neurol.
2022;3491:1–3.
31. Sousa D, Ftade J, Patrocinio J, et.al.
Monkeypox infection and bacterial cellulitis a
complication to look for Elsevier Enhanced
Reader. International Journal of Infectious
Disease. 2022;123:180–2.